Assessment of Quality of Life in Patients with Neuroendocrine Tumours: Results of a Systematic Literature Review

#2797

Introduction: Health related quality of life (HRQoL) is increasingly important as a concept reflecting the patients’ perspective in conjunction with the disease presentation severity and treatment. Understanding the impact of treatment on neuroendocrine tumour (NET) patients’ HRQoL is paramount given the nature of the disease.

Aim(s): To conduct a systematic literature review to identify literature reporting HRQoL data in patients with gastroenteropancreatic (GEP)-NETs between 1985 and 2019.

Materials and methods: The PRISMA guiding principles were applied. MEDLINE, Embase and the Cochrane library were searched. Data extracted from the publications included type of study, patient population data (mid-gut/hind-gut/GI-NET/P-NET), sample size, intervention/comparators, QoL instruments, average and data spread of overall and sub-scores, and follow-up time.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Fountain D, Leeuwenkamp O, Watson C, Longworth L,

Keywords: Gastro-entero-pancreatic neuroendocrine tumours, Quality of Life, 177Lu-Dotatate, EORTC QLQ-C30,